Literature DB >> 20494665

Effect of homocysteine-lowering B vitamin treatment on angiographic progression of coronary artery disease: a Western Norway B Vitamin Intervention Trial (WENBIT) substudy.

Kjetil H Løland1, Oyvind Bleie, Are J Blix, Elin Strand, Per M Ueland, Helga Refsum, Marta Ebbing, Jan E Nordrehaug, Ottar Nygård.   

Abstract

Total plasma homocysteine (tHcy) is an independent risk factor for coronary artery disease, and tHcy is lowered by B vitamins. To assess the effect of homocysteine-lowering B-vitamin treatment on angiographic progression of coronary artery disease, this substudy of the Western Norway B Vitamin Intervention Trial (WENBIT) included patients who had undergone percutaneous coronary intervention. The patients were randomized to daily oral treatment with folic acid, vitamin B(12), and vitamin B(6) or placebo in a 2 x 2 factorial design. The coronary angiograms obtained at baseline and follow-up were evaluated. The primary angiographic end points were the changes in minimum lumen diameter and diameter stenosis. A total of 348 subjects (288 men) with a mean +/- SD age of 60 +/- 10.2 years were followed up for a median of 10.5 months (twenty-fifth, seventy-fifth percentile 9.2, 11.8). The baseline median plasma tHcy level was 10.0 mumol/L (twenty-fifth, seventy-fifth percentile 8.1, 11.0), and treatment with folic acid/vitamin B(12) lowered the tHcy levels by 22%. At follow-up, we found 309 lesions with a significant decrease from baseline in the minimum lumen diameter of a mean of -0.16 +/- 0.4 mm and an increase in the diameter stenosis of 4.4 +/- 0.7%. Treatment with folic acid/vitamin B(12) or vitamin B(6) was not associated with a change in diameter stenosis or minimum lumen diameter. In a post hoc analysis, folic acid/vitamin B(12) treatment was significantly associated with rapid progression (odds ratio 1.84, 95% confidence interval 1.07 to 3.18). In conclusion, vitamin B treatment showed no beneficial effect on the angiographic progression of coronary artery disease, and the post hoc analyses suggested that folic acid/vitamin B(12) treatment might promote more rapid progression. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20494665     DOI: 10.1016/j.amjcard.2010.01.019

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  17 in total

Review 1.  Antioxidants and coronary artery disease: from pathophysiology to preventive therapy.

Authors:  Jane A Leopold
Journal:  Coron Artery Dis       Date:  2015-03       Impact factor: 1.439

2.  Failure of vitamin supplementation to lower the risk of recurrent stroke.

Authors:  Harold P Adams
Journal:  Curr Neurol Neurosci Rep       Date:  2011-02       Impact factor: 5.081

Review 3.  Coronary heart disease prevention: nutrients, foods, and dietary patterns.

Authors:  Shilpa N Bhupathiraju; Katherine L Tucker
Journal:  Clin Chim Acta       Date:  2011-05-07       Impact factor: 3.786

Review 4.  Combined methylmalonic acidemia and homocystinuria, cblC type. II. Complications, pathophysiology, and outcomes.

Authors:  Nuria Carrillo-Carrasco; Charles P Venditti
Journal:  J Inherit Metab Dis       Date:  2011-07-12       Impact factor: 4.982

Review 5.  Homocysteine-lowering interventions for preventing cardiovascular events.

Authors:  Arturo J Martí-Carvajal; Ivan Solà; Dimitrios Lathyris; Mark Dayer
Journal:  Cochrane Database Syst Rev       Date:  2017-08-17

6.  Interactions Between Nuclear Receptor SHP and FOXA1 Maintain Oscillatory Homocysteine Homeostasis in Mice.

Authors:  Hiroyuki Tsuchiya; Kerry-Ann da Costa; Sangmin Lee; Barbara Renga; Hartmut Jaeschke; Zhihong Yang; Stephen J Orena; Michael J Goedken; Yuxia Zhang; Bo Kong; Margitta Lebofsky; Swetha Rudraiah; Rana Smalling; Grace Guo; Stefano Fiorucci; Steven H Zeisel; Li Wang
Journal:  Gastroenterology       Date:  2015-02-19       Impact factor: 22.682

7.  Chronic Kidney Disease Induces Inflammatory CD40+ Monocyte Differentiation via Homocysteine Elevation and DNA Hypomethylation.

Authors:  Jiyeon Yang; Pu Fang; Daohai Yu; Lixiao Zhang; Daqing Zhang; Xiaohua Jiang; William Y Yang; Teodoro Bottiglieri; Satya P Kunapuli; Jun Yu; Eric T Choi; Yong Ji; Xiaofeng Yang; Hong Wang
Journal:  Circ Res       Date:  2016-11-11       Impact factor: 17.367

Review 8.  Versatile enzymology and heterogeneous phenotypes in cobalamin complementation type C disease.

Authors:  Anna J Esser; Srijan Mukherjee; Ilia A Dereven'kov; Sergei V Makarov; Donald W Jacobsen; Ute Spiekerkoetter; Luciana Hannibal
Journal:  iScience       Date:  2022-08-18

9.  The association between progression of atherosclerosis and the methylated amino acids asymmetric dimethylarginine and trimethyllysine.

Authors:  Kjetil H Løland; Oyvind Bleie; Heidi Borgeraas; Elin Strand; Per M Ueland; Asbjørn Svardal; Jan E Nordrehaug; Ottar Nygård
Journal:  PLoS One       Date:  2013-05-29       Impact factor: 3.240

10.  Effect of folic acid supplementation on levels of circulating Monocyte Chemoattractant Protein-1 and the presence of intravascular ultrasound derived virtual histology thin-cap fibroatheromas in patients with stable angina pectoris.

Authors:  Kjetil H Løland; Øyvind Bleie; Elin Strand; Per M Ueland; Jan E Nordrehaug; Hector M Garcia-Garcia; Patrick W Serruys; Ottar Nygård
Journal:  PLoS One       Date:  2013-07-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.